Singapore's Ion Investments Buys Another 10% Stake In Korea's Celltrion In Anticipation of 2012 Biosimilars Launch

SEOUL - Celltrion, Inc. said Sept. 1 that Singapore's Ion Investments B.V., a wholly-owned subsidiary of Temasek Holdings Pte. Ltd., purchased 10% of the outstanding shares of Celltrion Healthcare Co., Celltrion's global distribution and marketing arm, increasing the investor's share in the Korean company